menu
    • menu

    Company profile for Rakovina Therapeutics

    NEW Drugs in Dev: 5
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Rakovina Therapeutics, Inc. was founded in 2020 with a vision to transform and extend the lives of patients with cancer. Our team has deep experience in drug discovery research, preclinical and clinical development and regulatory affairs necessary to advance breakthrough innovations to become potential life-changing treatments in the oncology field. Our approach centers on using groundbreaking science to create new preci...
    Rakovina Therapeutics, Inc. was founded in 2020 with a vision to transform and extend the lives of patients with cancer. Our team has deep experience in drug discovery research, preclinical and clinical development and regulatory affairs necessary to advance breakthrough innovations to become potential life-changing treatments in the oncology field. Our approach centers on using groundbreaking science to create new precision medicines targeting critical DNA damage repair pathway mutations that are the hallmarks of many cancers. We are committed to conducting innovative cutting-edge research with the aim of benefiting patients worldwide.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Rakovina TherapeuticsCanada Flag
    Country
    Country
    Canada
    Address
    Address
    Suite 2201 – 8 Smithe Mews Vancouver, British Columbia
    Telephone
    Telephone
    1-604-619-0225
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.rakovinatherapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Rakovina Therapeutics To Unveil New Data At AACR Annual Meeting
    Rakovina Therapeutics To Unveil New Data At AACR Annual Meeting

    23 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/23/3260146/0/en/Rakovina-Therapeutics-to-Present-New-Data-at-the-AACR-Annual-Meeting-2026-World-s-Premier-Cancer-Research-Forum.html

    GLOBENEWSWIRE
    23 Mar 2026
    Share Share
    Rakovina Therapeutics Extends Non-Brokered Private Placement
    Rakovina Therapeutics Extends Non-Brokered Private Placement

    12 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/12/3255061/0/en/Rakovina-Therapeutics-Announces-Extension-of-Non-Brokered-Private-Placement.html

    GLOBENEWSWIRE
    12 Mar 2026
    Share Share
    Rakovina Closes $1M Debenture Unit Placement & Debt Settlements
    Rakovina Closes $1M Debenture Unit Placement & Debt Settlements

    05 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/06/3250782/0/en/Rakovina-Announces-Closing-of-1-Million-Debenture-Unit-Private-Placement-and-Debt-Settlement-Agreements.html

    GLOBENEWSWIRE
    05 Mar 2026
    Share Share
    Rakovina Reports Strong Validation After DDR Inhibitors Summit
    Rakovina Reports Strong Validation After DDR Inhibitors Summit

    04 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/04/3231802/0/en/Rakovina-Therapeutics-Reports-Strong-Industry-Validation-and-Emerging-Collaborations-Following-9th-Annual-DDR-Inhibitors-Summit.html

    GLOBENEWSWIRE
    04 Feb 2026
    Share Share
    Rakovina Therapeutics Reveals $1.5M Financing, Leadership
    Rakovina Therapeutics Reveals $1.5M Financing, Leadership

    27 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/27/3227046/0/en/Rakovina-Therapeutics-Announces-Corporate-Update-Including-up-to-1-5-Million-in-New-Financing-Leadership-Appointments-and-Debt-Restructuring.html

    GLOBENEWSWIRE
    27 Jan 2026
    Share Share
    Rakovina, Variational AI Expand ATR Inhibitor Collaboration
    Rakovina, Variational AI Expand ATR Inhibitor Collaboration

    08 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/08/3215081/0/en/Rakovina-Therapeutics-and-Variational-AI-Expand-Collaboration-to-Advance-Next-Generation-ATR-Inhibitors.html

    GLOBENEWSWIRE
    08 Jan 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search